Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CalciMedica Inc CALC

Healthcare
CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora... see more

Recent & Breaking News (NDAQ:CALC)

Graybug to Present at the 2022 ASCRS Annual Meeting

GlobeNewswire April 18, 2022

Graybug Vision Appoints Dirk Sauer to Board of Directors

GlobeNewswire April 13, 2022

Graybug Announces Pipeline Expansion, Current Cash Expected to Deliver Three Clinical Readouts in 2023

GlobeNewswire March 30, 2022

Graybug Vision to Host Virtual R&D Day on March 30, 2022

GlobeNewswire March 21, 2022

Graybug Vision Reports Full Year 2021 Financial Results and Recent Corporate Developments

GlobeNewswire March 10, 2022

Graybug to Participate in Three Upcoming Medical and Investor Conferences

GlobeNewswire February 3, 2022

Graybug Vision Makes Key Hires to Further Build Momentum Behind its Pipeline

GlobeNewswire January 20, 2022

Graybug Vision to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

GlobeNewswire November 15, 2021

Graybug Vision Announces Financial Results for the Three and Nine Months Ended September 30, 2021, and Recent Corporate Developments

GlobeNewswire November 11, 2021

Graybug Vision to Participate in the American Academy of Ophthalmology 2021 Annual Meeting

GlobeNewswire November 1, 2021

Graybug Vision to Participate in the Annual Ophthalmology Innovation Summit (OIS) Retina@ASRS Conference

GlobeNewswire September 30, 2021

Graybug Vision Reports Analysis of Data from the Six-Month Extension Study of the ALTISSIMO Phase 2b Trial in Wet AMD

GlobeNewswire September 28, 2021

Graybug Vision to Participate in the Cantor Virtual Global Healthcare Conference

GlobeNewswire September 21, 2021